Video

Combating Sleep Disorders in Parkinson's Disease

Author(s):

Aleksandar Videnovic, MD, associate professor at the Massachusetts General Hospital, discusses new patient monitoring opportunities and other methods of treatment for one of Parkinson's disease patients' most common symptoms.

Sleep disorder is prevalent in almost every Parkinson’s disease (PD) patient, worsening the efficacy of their own treatment and quality of life.

These disorders are not just about night-time sleep, Aleksandar Videnovic, MD, said. It’s about day-time function, and it includes a “rich phenotype” of disorders.

“Therefore, good treatment paradigm really needs to start with the discussion about symptoms leading to diagnosis,” Videnovic said.

Videnovic, associate professor at Massachusetts General Hospital, spoke about the debilitating effects of sleep disorder in PD patients the 21st International Congress of Parkinson’s Disease and Movement Disorders in Vancouber, BC. But treatment optimization and advancements in patient monitoring are aiding those it affects.

“We will certainly see more emphasis on important monitoring with these devices that are being specifically designed for the Parkinson’s disease population,” Videnovic said. “There are a lot of these sleep monitoring apps and paradigms that already in the market for available use for general sleep assessment.”

Videnovic sees these programs and apps coming into the mainstream of PD treatment, helping clinicians see the sleep dynamics of patients while not costing them the comfort of home care.

These advancements, as long as advocacy for healthy exercise and diet to supplement treatment efficacy, will aid those inflicted with one of PD’s most common and most difficult symptoms.

Related Videos
Marcelo Kugelmas, MD | Credit: South Denver Gastroenterology
John Tesser, MD, Adjunct Assistant Professor of Medicine, Midwestern University, and Arizona College of Osteopathic Medicine, and Lecturer, University of Arizona Health Sciences Center, and Arizona Arthritis & Rheumatology Associates
Brigit Vogel, MD: Exploring Geographical Disparities in PAD Care Across US| Image Credit: LinkedIn
Eric Lawitz, MD | Credit: UT Health San Antonio
| Image Credit: X
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Stephen Nicholls, MBBS, PhD | Credit: Monash University
Marianna Fontana, MD, PhD: Nex-Z Shows Promise in ATTR-CM Phase 1 Trial | Image Credit: Radcliffe Cardiology
Zerlasiran Achieves Durable Lp(a) Reductions at 60 Weeks, with Stephen J. Nicholls, MD, PhD | Image Credit: Monash University
© 2024 MJH Life Sciences

All rights reserved.